We are delighted to announce that PharmEnable have been selected to be part of KQ Labs, a prestigious accelerator programme for data-driven healthcare startups funded by Innovate UK and run by the Francis Crick Institute.
The Francis Crick Institute is an independent organisation dedicated to understanding the fundamental biology underlying health and disease. They are the biggest biochemical research facility under a single roof in Europe. Their aim is to translate findings into novel ways to prevent, diagnose and treat illnesses. The founding partners include the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL, Imperial College London and King’s College London.
This intensive 16-week programme offered by KQ Labs provides support to early stage, data-driven start-ups working at the interface between biomedical and data science. Teams are selected who are believed to have the potential to make an impact on global health outcomes. The KQ Academy aims to deliver mentoring and coaching to support, inspire and nurture the next generation of start-ups, to create future digital health leaders and aid business development.
KQ Labs’ unique focus on data driven healthcare is supported by Genomics England and Health Data Research UK. PharmEnable’s vision to provide an innovative, cost-effective and efficient ways to identify new drug candidates is matched well with the aims of KQ Labs.
Dr Jelena Aleksic, Chief Business Officer at PharmEnable, said: “We are delighted to have been selected in to the KQ Labs cohort. This specialist programme will help to push the business and our team forward and help accelerate business growth.”
